About Serina Therapeutics
Serina Therapeutics is a private company based in Huntsville, Alabama. It has reported $46,557,055 raised in nine offerings on Form D since September 2012. Its chief executive is Randall Moreadith.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 15, 2023 | Mar 30, 2023 | $10,000,000fully sold | 1 | $10.0M | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Nov 10, 2022 | Nov 14, 2022 | $3,650,000fully sold | 1 | $3.6M | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Jun 21, 2022 | Jul 15, 2022 | $1,000,000of $5.0M target | 3 | $333K | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Jul 1, 2019 | Jul 2, 2019amended Jun 2, 2021 | $3,681,009of $76.2M target | 12 | $306K | Equity, OptionsRule 506(b) | Form D/A ↗3 earlier filings |
| Jan 23, 2017 | Feb 2, 2017amended Apr 13, 2018 | $8,220,966of $32.5M target | 18 | $456K | EquityRule 506(b) | Form D/A ↗3 earlier filings |
| Apr 11, 2014 | Mar 20, 2014amended Mar 18, 2015 | $4,855,000of $6.2M target | 21 | $231K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Nov 4, 2010 | Oct 1, 2012 | $11,150,080fully sold | 36 | $309K | Equity06 | Form D ↗ |
| Mar 1, 2008 | Sep 21, 2012 | $2,000,000fully sold | 5 | $400K | Equity06 | Form D ↗ |
| Nov 27, 2006 | Sep 19, 2012 | $2,000,000fully sold | 4 | $500K | Equity06 | Form D ↗ |
| Total, nine offerings | $46,557,055 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Serina Therapeutics's Form D filed Mar 30, 2023.
BF
Barbara Fisk
Director
JJ
James Hudson, Jr.
Director
RM
Randall Moreadith
Chief Executive Officer and President, director
SL
Steve Ledger
Director
GD
Greg Bailey, M.D.
Director
JH
J Harris
Executive officer and director
TV
Tacey Viegas
Executive officer
MB
Michael Bentley
Executive officer and director
Earlier filings also listed Miguel Loya (director, last listed Nov 2022), Brendan Rae (executive officer, last listed Apr 2018) and Lonnie McMillian (director, last listed Oct 2012).
Sources
- SECSerina Therapeutics, Inc. Form D/A, filed Jun 10, 2020
- SECSerina Therapeutics, Inc. Form D/A, filed Mar 4, 2020
- SECSerina Therapeutics, Inc. Form D, filed Jul 2, 2019
- SECSerina Therapeutics, Inc. Form D/A, filed Jan 22, 2018
- SECSerina Therapeutics, Inc. Form D/A, filed May 24, 2017
- SECSerina Therapeutics, Inc. Form D, filed Feb 2, 2017
- SECSerina Therapeutics, Inc. Form D, filed Mar 20, 2014
- SECSerina Therapeutics, Inc. filing history